Nalaganje...
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
Therapeutic factor VIII is highly immunogenic. Despite intensive research in the last decades, the reasons why 5-30% of patients with hemophilia A (of all severities) develop inhibitory anti-factor VIII antibodies (inhibitors) following replacement therapy remain an enigma. Under physiological condi...
Shranjeno v:
| izdano v: | Haematologica |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ferrata Storti Foundation
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355482/ https://ncbi.nlm.nih.gov/pubmed/30514798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.206383 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|